Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.870
-0.030 (-1.03%)
At close: Jun 26, 2025, 4:00 PM
2.930
+0.060 (2.09%)
Pre-market: Jun 27, 2025, 9:01 AM EDT
Sana Biotechnology Stock Forecast
Stock Price Forecast
The 5 analysts that cover Sana Biotechnology stock have a consensus rating of "Strong Buy" and an average price target of $9.5, which forecasts a 231.01% increase in the stock price over the next year. The lowest target is $5 and the highest is $15.
Price Target: $9.5 (+231.01%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sana Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +74.22% | Jun 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +283.28% | Apr 24, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +74.22% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +283.28% | Mar 18, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +143.90% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
n/a
from 94.93M
Revenue Next Year
n/a
EPS This Year
-0.78
from -1.16
EPS Next Year
-0.75
from -0.78
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.67 | -0.57 | -0.46 | ||
| Avg | -0.78 | -0.75 | -0.81 | ||
| Low | -0.88 | -0.89 | -1.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.